EasyDNNNews
MGH Researchers Develop AI Tool to Predict Melanoma Recurrence

MGH Researchers Develop AI Tool to Predict Melanoma Recurrence

A team of scientists at Massachusetts General Hospital has developed a new tool that uses AI to predict which patients are most likely to experience a recurrence of melanoma. Read the blog to learn how this research may lead to more effective treatment for patients in the early stages of melanoma.


Contact Us: 202.293.5003 x4
sales@madwolf.com
Phone:202.293.5003    Sales:202.293.5003 x4   info@madwolf.com